Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Live attenuated versus inactivated influenza vaccine in infants and young children.

Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group.

N Engl J Med. 2007 Feb 15;356(7):685-96. Erratum in: N Engl J Med. 2007 Mar 22;356(12):1283.

2.
3.

Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.

Vesikari T, Karvonen A, Smith HM, Dunning A, Razmpour A, Saville MK, Gruber WC, Forrest BD.

Pediatrics. 2008 Mar;121(3):e568-73. doi: 10.1542/peds.2007-1405. Epub 2008 Feb 25.

PMID:
18299305
4.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
5.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.

N Engl J Med. 1998 May 14;338(20):1405-12.

6.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
7.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
8.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948
9.

Emerging data on the safety and efficacy of influenza vaccines in children.

Vesikari T.

Pediatr Infect Dis J. 2008 Nov;27(11 Suppl):S159-61. doi: 10.1097/INF.0b013e31818a545d.

PMID:
18955892
10.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
11.

Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.

Block SL, Toback SL, Yi T, Ambrose CS.

Clin Ther. 2009 Oct;31(10):2140-7. doi: 10.1016/j.clinthera.2009.09.014.

PMID:
19922885
12.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
13.

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

Belshe RB, Ambrose CS, Yi T.

Vaccine. 2008 Sep 12;26 Suppl 4:D10-6. doi: 10.1016/j.vaccine.2008.06.083.

PMID:
18611422
14.

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.

Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2549-57. Epub 2012 Mar 14.

15.

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, Rajamohanan KP, Narayanan SN, Kirubakaran C, Rappaport R, Razmpour A, Gruber WC, Forrest BD; Pan-Asian CAIV-T Pediatric Efficacy Trial Network.

Pediatr Infect Dis J. 2007 Jul;26(7):619-28.

PMID:
17596805
16.

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.

Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD; CAIV-T Pediatric Day Care Clinical Trial Network.

Pediatrics. 2006 Dec;118(6):2298-312.

PMID:
17142512
17.

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.

PMID:
18462851
18.

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.

Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF.

Ann Intern Med. 1992 Oct 15;117(8):625-33.

PMID:
1530193
19.

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.

Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD; D153-P504 LAIV Study Group.

Pediatr Infect Dis J. 2009 May;28(5):365-71. doi: 10.1097/INF.0b013e31819219b8.

PMID:
19395948
20.

Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.

Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP.

Pediatr Infect Dis J. 2008 May;27(5):444-52. doi: 10.1097/INF.0b013e3181660c2e.

PMID:
18401289

Supplemental Content

Support Center